Stone RL - Search Results

1

Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus.

Zheng G, Richmond A, Liu C, Berrebi A, Pallavajjala A, Haley L, Stone RL, McCarthy E, Vang R, Xing D. Zheng G, et al. Among authors: stone rl. Int J Gynecol Pathol. 2019 Sep;38(5):414-419. doi: 10.1097/PGP.0000000000000511. Int J Gynecol Pathol. 2019. PMID: 29629977

2

The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.

Tanner EJ, Ojalvo L, Stone RL, Levinson K, Temkin SM, Murdock T, Vang R, Sinno AK, Fader AN. Tanner EJ, et al. Among authors: stone rl. Int J Gynecol Cancer. 2017 Sep;27(7):1416-1421. doi: 10.1097/IGC.0000000000001047. Int J Gynecol Cancer. 2017. PMID: 30814241 Clinical Trial.

3

Chau DB, Beavis AL, Ronnett BM, Jenson E, Gocke CD, Anderson J, Nickles Fader A, Stone R. Chau DB, et al. Int J Gynecol Pathol. 2020 Jul;39(4):367-372. doi: 10.1097/PGP.0000000000000607. Int J Gynecol Pathol. 2020. PMID: 31033803

4

Paraneoplastic nodular regenerative hyperplasia of the liver associated with placental site trophoblastic tumor.

Dumas K, Wilbur M, Dillon J, Cliby W, Langstraat C, Fader AN, Xing D, Stone RL. Dumas K, et al. Among authors: stone rl. Gynecol Oncol Rep. 2019 May 18;29:16-19. doi: 10.1016/j.gore.2019.05.003. eCollection 2019 Aug. Gynecol Oncol Rep. 2019. PMID: 31193692 Free PMC article.

5

Placental site trophoblastic tumor versus exaggerated placental site: a diagnostic dilemma.

Katebi Kashi P, Hopkins MR, Stone RL. Katebi Kashi P, et al. Among authors: stone rl. Int J Gynecol Cancer. 2021 Oct;31(10):1391-1392. doi: 10.1136/ijgc-2021-003021. Int J Gynecol Cancer. 2021. PMID: 34607823 No abstract available.

6

Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence.

Hall C, Stone RL, Gehlot A, Zorn KK, Burnett AF. Hall C, et al. Among authors: stone rl. Int J Gynecol Cancer. 2016 Feb;26(2):313-7. doi: 10.1097/IGC.0000000000000603. Int J Gynecol Cancer. 2016. PMID: 26588235

7

The Use of "Optimal Cytoreduction" Nomenclature in Ovarian Cancer Literature: Can We Move Toward a More Optimal Classification System?

Angarita AM, Stone R, Temkin SM, Levinson K, Fader AN, Tanner EJ. Angarita AM, et al. Int J Gynecol Cancer. 2016 Oct;26(8):1421-7. doi: 10.1097/IGC.0000000000000796. Int J Gynecol Cancer. 2016. PMID: 27575626

8

Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.

Ricci S, Stone RL, Fader AN. Ricci S, et al. Among authors: stone rl. Gynecol Oncol. 2017 Apr;145(1):208-216. doi: 10.1016/j.ygyno.2017.02.019. Epub 2017 Feb 13. Gynecol Oncol. 2017. PMID: 28209496 Review.

9

Risk of empty lymph node packets in sentinel lymph node mapping for endometrial cancer using indocyanine green.

Thomaier L, Jager L, Stone R, Wethington S, Fader A, Tanner EJ. Thomaier L, et al. Int J Gynecol Cancer. 2019 Mar;29(3):513-517. doi: 10.1136/ijgc-2019-000215. Int J Gynecol Cancer. 2019. PMID: 30833439

10

Peritoneal tuberculosis: the great mimicker.

Varghese A, Fader A, Wilbur M, Salimian K, Azadi JR, Johnson PT, Stone R. Varghese A, et al. Int J Gynecol Cancer. 2020 Apr;30(4):546-550. doi: 10.1136/ijgc-2020-001291. Epub 2020 Mar 9. Int J Gynecol Cancer. 2020. PMID: 32156716 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters